These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14727986)

  • 1. Secondary prevention of coronary artery disease with antimicrobials: current status and future directions.
    Muhlestein JB
    Am J Cardiovasc Drugs; 2002; 2(2):107-18. PubMed ID: 14727986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic treatment of atherosclerosis.
    Muhlestein JB
    Curr Opin Lipidol; 2003 Dec; 14(6):605-14. PubMed ID: 14624138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis].
    Grabczewska Z; Nartowicz E
    Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics.
    Dunne M
    Am Heart J; 1999 Nov; 138(5 Pt 2):S542-4. PubMed ID: 10539870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis.
    Fong IW
    CMAJ; 2000 Jul; 163(1):49-56. PubMed ID: 10920732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.
    Girard SE; Temesgen Z
    Expert Opin Pharmacother; 2001 May; 2(5):765-72. PubMed ID: 11336621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections and atherosclerosis.
    Leinonen M; Saikku P
    Scand Cardiovasc J; 2000; 34(1):12-20. PubMed ID: 10816055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections: a cause of artery-clogging plaques?
    Gura T
    Science; 1998 Jul; 281(5373):35,37. PubMed ID: 9679016
    [No Abstract]   [Full Text] [Related]  

  • 12. The possible role of infections in acute myocardial infarction.
    Meier CR
    Biomed Pharmacother; 1999 Oct; 53(9):397-404. PubMed ID: 10554674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
    Fong IW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T; Stassen FR; Schurink GW; Tordoir JH; Welten RJ; van den Akker LH; Kurvers HA; Bruggeman CA; Kitslaar PJ
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):403-11. PubMed ID: 15749042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is atherosclerosis an infectious disease?
    Mawhorter SD; Lauer MA
    Cleve Clin J Med; 2001 May; 68(5):449-58. PubMed ID: 11352325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis].
    Persson K; Boman J
    Lakartidningen; 1998 May; 95(20):2334-6, 2339-40. PubMed ID: 9630800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
    Grayston JT
    J Infect Dis; 2000 Jun; 181 Suppl 3():S402-10. PubMed ID: 10839724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Far from verified: the infection hypothesis of arteriosclerosis. Antibiotics for heart patients? (interview by Dipl. Biol. Waltraud Paukstadt)].
    Richardt G
    MMW Fortschr Med; 2001 Oct; 143(40):12. PubMed ID: 11692837
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.